论文部分内容阅读
目的观察克赛联合来适可治疗短暂性脑缺血TIA疗效及安全性。方法将短暂性脑缺血发作患者50例随机分为两组,治疗组25例:克赛皮下注射0.4m l,每12h 1次,共10d,同时每晚口服来适可40mg共3个月。对照组25例:低分子右旋糖酐500m l加复方丹参针30m l,每d 1次静脉滴注,共10d,然后口服复方丹参片共3个月。观察两组疗效。结果治疗组有效率92%,对照组有效率60%,治疗组疗效高于对照组。结论克赛联合来适可治疗短暂性脑缺血疗效好且安全,值得临床推广。
Objective To observe the curative effect and safety of combination of ketamine and adjuvant to treat transient ischemic TIA. Methods Fifty patients with transient ischemic attack were randomly divided into two groups. The treatment group consisted of 25 cases: Kese subcutaneous injection of 0.4ml, every 12h for 10 days, and 40mg orally every night for 40 months for 3 months. Control group of 25 patients: low molecular weight dextran 500m l plus compound danshen needle 30m l, d every 1 times intravenous infusion, a total of 10d, and then oral compound danshen tablets for 3 months. The two groups were observed. Results The effective rate of the treatment group was 92%, the control group was 60%, the treatment group than the control group. Conclusions Kesai combined with suitable for the treatment of transient ischemic injury effective and safe, worthy of clinical promotion.